MICHAEL JOHN TOMSICEK - Chief Financial Officer at CRISPR Therapeutics AG

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
CRSP on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by MICHAEL JOHN TOMSICEK since 06 Mar 2025

Holdings reported by MICHAEL JOHN TOMSICEK for CRISPR Therapeutics AG

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 1,891 $118,193 $62.50 06 Aug 2021 Direct
Stock Option (Right to Buy) 131,000 11 Mar 2021 Direct Common Shares

Transactions reported by MICHAEL JOHN TOMSICEK for CRISPR Therapeutics AG

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.